Ipca Labs.

IPCALABORATORIES12 Apr 2024
Pharmaceuticals
+8.15 (+0.61%)
Lowest Today
Highest Today
Prev. Close
Today’s Open
52 Week High
52 Week Low
To Invest in Ipca Labs.
Ipca Labs.
Pharmaceuticals
IPCALABORATORIES12 Apr 2024
+8.15 (+0.61%)
OverviewFundamentals
Corporate action
Peer comparison
Income Sheet
Balance sheet
Cash flow
Share holding
About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.
Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Ipca Laboratories Ltd
₹1,339.00(+8.15/0.61%)
1,339.00+8.1533,764.2361.9361.285.44
Lupin Ltd
₹1,622.25(+17.65/1.10%)
1,622.25+17.6573,120.06138.7235.503.80
J B Chemicals & Pharmaceuticals Ltd
₹1,799.80(+41.50/2.36%)
1,799.80+41.5027,287.9071.1253.9210.17
Brooks Laboratories Ltd
₹105.40(-2.15/-2.00%)
105.40-2.15282.2858.350.004.06
Sanofi India Ltd
₹8,468.20(+17.45/0.21%)
8,468.20+17.4519,462.0842.3732.9519.16
399.75+3.752,324.7416.3613.451.46

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.
Promoter Shareholding
46.29%
FII Shareholding
10.27%
DII Shareholding
34.52%
Public Shareholding
8.92%
**Promoter pledged shareholding  46.29%

About Ipca Laboratories Ltd

Ipca Laboratories Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 33737.59 crores. It has reported a sales of Rs. 1506.83 crores and a net profit of Rs. 136.94 crores for the quarter ended December 2018. The company management includes Premchand Godha, Premchand Godha,A K Jain,Pranay Godha,Prashant Godha,Anand T Kusre,Manisha Premnath,Kamal Kishore Seth,Narendra Mairpady,Harish P Kamath (Ipca Laboratories Ltd) among others.
Chairman
Premchand Godha
Registered office
48 Kandivli Industrial Estate,Kandivli (West),Mumbai,Maharashtra,400067
FAX :91-22-28686613
Background
Incorporation Year1949
Face Value₹1
Market Lot1

How to buy Ipca Labs. shares on nse?

To buy Ipca Labs. shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Ipca Labs. share price today?

The Ipca Labs. shares price on nse is Rs.1339 today.

What is the market cap of Ipca Labs. shares on NSE ?

The company has a market capitalization of Rs.33764.23Cr

What is the PE & PB ratio of Ipca Labs. shares ?

PE is 61.28 and PB is 5.44

What is the 52 Week High and Low of Ipca Labs. shares?

Ipca Labs. stock price high: Rs.1348.1 Ipca Labs. stock price low: Rs.669.8

Is Ipca Labs a government-run institution?

No, IPCA Laboratories is not a government-run organization. It is a privately-owned pharmaceutical company based in India. IPCA Laboratories was founded in 1949 and has since grown to become one of the leading pharmaceutical companies in India.

Who is Ipca Labs’ owner?

IPCA Laboratories is a publicly-traded company and its ownership is spread among its shareholders. The Promoter of IPCA Labs is Mr. Premchand Godha and his family.

How well is Ipca Labs doing?

IPCA Laboratories operates in the pharmaceutical industry and has a diverse product portfolio that includes medicines for various therapeutic segments, including antimalarials, anti-bacterial, pain management, and cardiovascular drugs.

Ipca Labs’ consolidated revenue has gone from Rs. 3773.18 crores in March 2019 to  Rs. 5,829.79 crores on 31 March 2022. The net profit has gone from Rs. 443.03 crores to Rs. 910.95 crores in the same period.

Ipca Labs stock has given a positive return of 10.05% over the past three years and a negative return of -18.57% over the past one year.

 

What are the latest results of Ipca Labs?

The last fiscal result of Ipca Labs was declared in March 2022 and they reported a consolidated revenue of INR 5,829.79 crore and net profit of Rs. 910.95 crores.

What are the potential catalysts that positively impact the stock price of Ipca lab?

Some potential catalysts that may positively affect IPCA Laboratories' stock price could include:

  • Strong financial results
  • Expansion in new markets
  • Launch of new products
  • Regulatory approvals
  • Industry trends